DOMH

Dominari Holdings

--(--)

Market Open: --

--(--)

Post-Market: --

Signals Analysis

Buy signal 1

Sell signal 0

stock price surged significantly

Key Stats

--DAY`S RANGE--

--52 WK RANGE--

Open

Prev.Close

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

Low

52 Week High

52 Week Low

About DOMH

Dominari Holdings Inc.

A biotechnology company developing a variety of small molecule anticancer and antiviral therapies

Industry

Capital market

Established Date

Invalid Date

Listing Date

Invalid Date

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.dominari.com

Security Type

Common stock

Office address

725 5th Avenue, 22nd Floor, New York, NY 10022

Business

Introduction

Dominari Holdings Inc., was founded in Delaware in 1967. The company is a holding company engaged in financial services, investment advisory and wealth management, asset management, investment banking, acquiring interests in high-growth industries, and biotechnology and pharmaceutical research and development through its various subsidiaries.

Company Financials

EPS

DOMH has released its 2023 Q1 earnings. EPS was reported at -0.71, versus the expected 0.00, missing expectations. The chart below visualizes how DOMH has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

DOMH has released its 2024 Q3 earnings report, with revenue of 4.04M, reflecting a YoY change of 319.83%, and net profit of -4.21M, showing a YoY change of -18.92%. The Sankey diagram below clearly presents DOMH’s revenue sources and cost distribution.